Appraisal in progress
Indication |
|
| Status: In progress | |
For the treatment of patients with moderate to severe pemphigus vulgaris. |
|
Medicine details |
|
| Medicine name | rituximab (MabThera®) |
| Formulation | 100mg concentrate for solution for infusion, 500mg concentrate for solution for infusion |
| Reference number | 3192 |
| Indication | As above |
| Company | Roche Products Ltd |
| BNF chapter | Skin |
| Submission type | Directed |
| Status | In progress |
| NMG meeting date | 06/07/2022 |
| AWMSG meeting date | 14/09/2022 |
| Date of issue | TBC |